Sei Investments CO Immunocore Holdings PLC Transaction History

Sei Investments CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$60.14 - $75.36 $6,434 - $8,063	107 Added 1.88%	5,807 $377,000
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $964,424 - $1.56 Million	-22,507 Reduced 79.79%	5,700 $389,000
Q3 2023 Nov 14, 2023	BUY	$49.5 - $66.6 $30,690 - $41,292	620 Added 2.25%	28,207 $1.46 Million
Q2 2023 Aug 11, 2023	SELL	$48.54 - $61.64 $692,520 - $879,417	-14,267 Reduced 34.09%	27,587 $1.65 Million
Q1 2023 May 12, 2023	BUY	$46.12 - $65.71 $1.36 Million - $1.93 Million	29,390 Added 235.8%	41,854 $2.07 Million
Q4 2022 Feb 10, 2023	SELL	$45.51 - $65.08 $739,947 - $1.06 Million	-16,259 Reduced 56.61%	12,464 $711,000
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $1.07 Million - $1.65 Million	28,723 New	28,723 $1.35 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.